Text Size

A A A

Search


 

Home | Clinical Trials

FDA Approved Drugs » 1999
Medical Areas: Neurology

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names

Lamictal (lamotrigine) Chewable Dispersible Tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoSmithKline
Approval Status: Approved June 1999
Treatment Area: Neurology

General Information

The approval of these efficacy supplements provide for the use of Lamictal as conversion to monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-inducing antiepileptic drug.


 Back to Top | Printer Friendly Version

Get Involved

Stroke and You

Our Mission Statement

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org